Antitrust Antitrust

Spanish radiopharmacy cartel detected thanks to in-house research, says CNMC boss

By Nicholas Hirst
  • 24 Feb 2021 11:09
  • 24 Feb 2021 11:15

A cartel between two Spanish pharmaceutical companies that were fined almost 6 million euros ($7.3 million) was uncovered by the national competition authority's in-house detection unit, according to the agency's boss.

The source of the case is noteworthy because competition authorities across Europe — faced with falling leniency requests from cartelists —

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News